CN102600313A - Medicinal composition for treating polycystic ovary syndrome - Google Patents

Medicinal composition for treating polycystic ovary syndrome Download PDF

Info

Publication number
CN102600313A
CN102600313A CN2012101086744A CN201210108674A CN102600313A CN 102600313 A CN102600313 A CN 102600313A CN 2012101086744 A CN2012101086744 A CN 2012101086744A CN 201210108674 A CN201210108674 A CN 201210108674A CN 102600313 A CN102600313 A CN 102600313A
Authority
CN
China
Prior art keywords
grams
polycystic ovary
ovary syndrome
medicinal composition
treating polycystic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012101086744A
Other languages
Chinese (zh)
Other versions
CN102600313B (en
Inventor
郑瑞芹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210108674.4A priority Critical patent/CN102600313B/en
Publication of CN102600313A publication Critical patent/CN102600313A/en
Application granted granted Critical
Publication of CN102600313B publication Critical patent/CN102600313B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicinal composition for treating polycystic ovary syndrome. The medicinal composition is characterized by comprising the following medicinal components by weight: 8g of processed pangolin, 12g of eucommia bark, 12g of Chinese dodder seed, 8g of chicken's gizzard-membrane, 20g of processed rehmannia, 12g of epimedium herb, and 3g of safflower. The medicinal composition for treating the polycystic ovary syndrome has the advantages of high cure rate, low raw material price and no harm to patient after healing.

Description

A kind of pharmaceutical composition of treating polycystic ovary syndrome
Technical field
The present invention relates to a kind of medicine of treating infertility, be specially a kind of pharmaceutical composition of treating polycystic ovary disease.
Background technology
Because the influence of each side factor congenital or posteriority, infertility is perplexing a plurality of families always, also is the field that medical circle constantly deepens to study all the time.
Polycystic ovary syndrome (polycystic ovarian syndrome) is a kind of reproductive function obstacle and abnormal carbohydrate metabolism and the endocrine regulation syndrome deposited.Because of ovulation failure causes infertile then is the main clinical manifestation of polycystic ovarian syndrome.The definite cause of disease of polycystic ovary syndrome is not quite clear, thinks that at present ovary produces too much androgen, and androgenic excessive generation is owing to the synergistic result of multiple hormonal system dysfunction in the body.
Therapeutic Method for polycystic ovary syndrome is divided into doctor trained in Western medicine and traditional Chinese medical science dual mode at present: mostly the Therapeutic Method of doctor trained in Western medicine is operation and instrument treatment, big to person infringement property, and healing is not thorough, and with high costs; The existing traditional Chinese medical science then also is to adopt Drug therapy, but DeGrain, and complicated operation.
Therefore, providing a kind of cure rate high, and cure the medicine that afterwards person is not had the novel therapeutic polycystic ovary syndrome of injury, has been a urgent problem.
Summary of the invention
In order to overcome above-mentioned deficiency of the prior art, it is high to the invention provides a kind of cure rate, and cures the back does not have the novel therapeutic polycystic ovary syndrome of injury to patient body pharmaceutical composition.
The objective of the invention is to realize like this:
A kind of pharmaceutical composition of treating polycystic ovary syndrome is characterized in that, is formed by following medicine components proportioning: stir-baked SQUAMA MANITIS, the Cortex Eucommiae, Semen Cuscutae, Endothelium Corneum Gigeriae Galli, Radix Rehmanniae Preparata, Herba Epimedii, Stigma Croci;
Described component quality proportioning is: stir-baked SQUAMA MANITIS 8 grams, the Cortex Eucommiae 12 grams, Semen Cuscutae 12 grams, Endothelium Corneum Gigeriae Galli 8 grams, Radix Rehmanniae Preparata 20 grams, Herba Epimedii 12 grams, Stigma Croci 3 grams.
Actively helpful effect: medicine composite for curing polycystic ovary syndrome cure rate provided by the invention is high, and raw material is cheap, and cures the back patient is not had injury.
The specific embodiment:
Below in conjunction with the specific embodiment, the present invention is further described:
A kind of pharmaceutical composition of treating polycystic ovary syndrome is characterized in that, is formed by following medicine components proportioning: stir-baked SQUAMA MANITIS, the Cortex Eucommiae, Semen Cuscutae, Endothelium Corneum Gigeriae Galli, Radix Rehmanniae Preparata, Herba Epimedii, Stigma Croci;
Described component quality proportioning is: stir-baked SQUAMA MANITIS 8 grams, the Cortex Eucommiae 12 grams, Semen Cuscutae 12 grams, Endothelium Corneum Gigeriae Galli 8 grams, Radix Rehmanniae Preparata 20 grams, Herba Epimedii 12 grams, Stigma Croci 3 grams.
Pharmacology analysis:
Stir-baked SQUAMA MANITIS
The stir-baked SQUAMA MANITIS nature and flavor are salty, be slightly cold: return liver, kidney channel.Main effect is promoting blood circulation to restore menstrual flow, detumescence and apocenosis.
Stir-baked SQUAMA MANITIS is good at walking to scurry, and property specially row is loose, and the power of promoting blood circulation to remove blood stasis is stronger, can the tonneau meridians and through sick institute.
The Cortex Eucommiae
Cortex Eucommiae nature and flavor are sweet, warm: return liver, kidney channel.Main effect is invigorating the liver and kidney, bone and muscle strengthening, antiabortive.
The Cortex Eucommiae is good at invigorating the liver and kidney and leak-stopping is antiabortive.Cortex Eucommiae decoct and alcohol extract can resist the uteri excitation effect that pituitrin and acetylcholine cause, make the recover of uterus of contraction state normal.
Semen Cuscutae
The Semen Cuscutae nature and flavor are hot, sweet, flat; Return the liver,spleen,kidney warp.Main effect is that YANG invigorating tonifying YIN, warming the spleen nourish blood.
Semen Cuscutae cures mainly kidney Qi deficiency, dysfunction of the kidney in storing essence, and women's leukorrhagia, metrorrhagia reach ovarian disease incessantly.Can strengthen the cardiac contractile force of the white mice of exsomatizing, and isolated uterine is had excitation.
Endothelium Corneum Gigeriae Galli
The Endothelium Corneum Gigeriae Galli nature and flavor are sweet, flat; Return spleen, stomach, small intestinal, urinary bladder channel.Main effect is that activating the spleen helps digestion, controlling nocturnal emission with astringent drugs ends something lost.
Radix Rehmanniae Preparata
Sweet, the tepor of Radix Rehmanniae Preparata nature and flavor; Return liver, kidney channel.Main effect is nourishing the blood and yin, vital essence replenishing and marrow benifiting.
Radix Rehmanniae Preparata cures mainly blood deficiency disease; Menoxenia, disintegration; Hepatic and renal YIN deficiency disease.The married woman is this with blood, and blood is suitable with full smoothness.Menoxenia is often because of due to blood deficiency and the blood stasis.Radix Rehmanniae Preparata sweet in the mouth tepor, matter are grown quiet keeping and the kind yin nourishing of enriching blood, so can be used for disease such as menoxenia, it is suitable especially that blood deficiency does not have stagnant person.
Herba Epimedii
The Herba Epimedii nature and flavor are hot, sweet, warm; Return liver, kidney channel.Main effect is kidney invigorating and YANG supporting, wind-damp dispelling.
The hot warm-dryness syndrome of Herba Epimedii looses, and the damp of can dispeling the wind, the gas that again can temperature activates yang promote blood operation, and capable the ending bitterly of blood and muscle soft pulse profit is nourished should be used it so treat the women's ovary disease.
Stigma Croci
The Stigma Croci nature and flavor are hot, warm; GUIXIN, Liver Channel.Main effect is the blood circulation promoting and blood stasis dispelling dysmenorrhea.
Stigma Croci is invigorated blood circulation, and is good to stimulate the menstrual flow, and has the effect of stimulating the menstrual flow of stronger blood circulation promoting and blood stasis dispelling, cures mainly married woman's stasis and stimulates the menstrual flow, amenorrhea, no settled date of warp etc.
Embodiment 1
Thank so-and-so, the woman, 27 years old, people from Anyang, Henan Province, on August 21st, 2010 institute went to a doctor to me.Marry and do not see pregnancy in 3 years, after the color ultra inspection of local hospital, diagnosis is a polycystic ovary syndrome.Adopt Western medicine to cure not see half a year obvious curative effects in local hospital, after arrive Beijing hospital admission again, the doctor advises operative treatment, patient considers that operation risk is big, the relapse rate height, reasons such as expense height have been abandoned operative treatment.After onlap through our coloured silk and to look into patient's ovary image: 4.9 * 2.1 centimetres of visible 40 left and right sides follicles of right ovary size, bigger 0.4 * 0.4 centimetre; 5.5 * 1.6 centimetres of left side ovary sizes, visible 40 left and right sides follicles, bigger 0.4 * 0.4 centimetre, just be diagnosed as polycystic ovary syndrome, combine again the traditional Chinese medical science prestige, hear, ask, palpation is disconnected, the patient belongs to the polycystic ovary syndrome that the liver,spleen,kidney functional disorder causes.I doctor of institute combines patient's s own situation, has left the conditioning viscera body function to her, the Chinese medicine of main harmonizing the liver and spleen kidney: stir-baked SQUAMA MANITIS 12 grams, the Cortex Eucommiae 12 grams, Semen Cuscutae 13 grams, Endothelium Corneum Gigeriae Galli 10 grams, Radix Rehmanniae Preparata 22 grams, Herba Epimedii 10 grams, Stigma Croci 3 grams.Every day potion, it is for oral administration to fry in shallow oil soup, serve on 30 days after check.
On JIUYUE 20th, 2010 checked, and the whole health of patient is more a lot of than getting well in the past, and color ultra inspection intrauterine follicle diminishes gradually, disappears.The side does not change, and lets her serve on two months again.Follow up a case by regular visits to after half a year, it is just normal that the bimestrial originally medicine of patient's private prosecution does not finish off menstruation, just conceived during the drug withdrawal one and a half months.After repeatedly phone is followed up a case by regular visits to, do not see the disease that discomfort is arranged.
Experimental data
Treatment polycystic ovary disease, stir-baked SQUAMA MANITIS 8 grams, the Cortex Eucommiae 12 grams, Semen Cuscutae 12 grams, Endothelium Corneum Gigeriae Galli 8 grams, Radix Rehmanniae Preparata 20 grams, Herba Epimedii 12 grams, Stigma Croci 3 grams, with the disease plus-minus, every day potion; It is for oral administration to fry in shallow oil soup, and serveing on 30 doses is a course of treatment, and sick the lighter can be healed two courses of treatment, and heavy person needs to treat 3 courses of treatment continuously; Treat polycystic ovary 3869 examples altogether, 3733 examples of fully recovering account for 96.5%; Effective 121 examples account for 3.1%, and only 15 examples are invalid.Responding time is 15-27 days, is mostly about 22 days, generally in 70 days, cures.
Above embodiment only is used to explain preferred implementation of the present invention; But the present invention is not limited to above-mentioned embodiment; In the ken that said field those of ordinary skill is possessed; Any modification of being done within spirit of the present invention and the principle, be equal to and substitute and improvement etc., it all should be encompassed within the technical scheme scope that the present invention asks for protection.

Claims (2)

1. a pharmaceutical composition of treating polycystic ovary syndrome is characterized in that, is formed by following medicine components proportioning: stir-baked SQUAMA MANITIS, the Cortex Eucommiae, Semen Cuscutae, Endothelium Corneum Gigeriae Galli, Radix Rehmanniae Preparata, Herba Epimedii, Stigma Croci.
2. according to the described a kind of pharmaceutical composition of treating polycystic ovary syndrome of right, it is characterized in that: described each component according to the quality proportioning is: stir-baked SQUAMA MANITIS 8 grams, the Cortex Eucommiae 12 grams, Semen Cuscutae 12 grams, Endothelium Corneum Gigeriae Galli 8 grams, Radix Rehmanniae Preparata 20 grams, Herba Epimedii 12 grams, Stigma Croci 3 grams.
CN201210108674.4A 2012-04-15 2012-04-15 Medicinal composition for treating polycystic ovary syndrome Expired - Fee Related CN102600313B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210108674.4A CN102600313B (en) 2012-04-15 2012-04-15 Medicinal composition for treating polycystic ovary syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210108674.4A CN102600313B (en) 2012-04-15 2012-04-15 Medicinal composition for treating polycystic ovary syndrome

Publications (2)

Publication Number Publication Date
CN102600313A true CN102600313A (en) 2012-07-25
CN102600313B CN102600313B (en) 2014-02-26

Family

ID=46518332

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210108674.4A Expired - Fee Related CN102600313B (en) 2012-04-15 2012-04-15 Medicinal composition for treating polycystic ovary syndrome

Country Status (1)

Country Link
CN (1) CN102600313B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101049405A (en) * 2007-05-16 2007-10-10 北京艺信堂医药研究所 Preparation of Chinese traditional medicine for treating barrenness caused by obstruction of ovulation
CN101890081A (en) * 2009-05-19 2010-11-24 李鑫 Formula of Chinese medicament for treating female infertility and processing method of Chinese medicament

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101049405A (en) * 2007-05-16 2007-10-10 北京艺信堂医药研究所 Preparation of Chinese traditional medicine for treating barrenness caused by obstruction of ovulation
CN101890081A (en) * 2009-05-19 2010-11-24 李鑫 Formula of Chinese medicament for treating female infertility and processing method of Chinese medicament

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李淑女等: "名老中医治疗多囊卵巢综合征临床经验浅析", 《中医临床研究》 *

Also Published As

Publication number Publication date
CN102600313B (en) 2014-02-26

Similar Documents

Publication Publication Date Title
CN101700288B (en) Medicine patch for treating infertility caused by cold uterus and preparation method thereof
CN102302659B (en) Chinese medicinal composition for kidney-yang deficiency and phlegm-retention type polycystic ovanian syndrome
CN105695273A (en) Health-care wine
CN105079184A (en) Medicine for treating osteoporosis
CN1879838A (en) A Chinese medicine for treating threatened abortion
CN104688929A (en) Traditional Chinese medicine for treating liver-kidney deficiency type dysmenorrhea
CN101862414B (en) Chinese medicinal composition for treating impotence
CN104547736A (en) Medicine for treating goiter
CN101422547B (en) Traditional Chinese medicine for treating kidney-deficiency blood-insufficiency type amenorrhea
CN102600313B (en) Medicinal composition for treating polycystic ovary syndrome
CN104189268B (en) A kind of Chinese materia medica preparation for treating postpartum irregular menstruation
CN102247505A (en) Chinese medical composition for treating sterility of multiparous cow after repeated mating and treatment method of sterility of multiparous cow after repeated mating
CN102579605A (en) Oral Chinese medicinal composition for treating bone fracture diseases
CN106860717A (en) It is a kind of to treat infertile medicine
CN101129630B (en) Medicament for treating rheumatism, arthritis pauperum
CN104548051A (en) Traditional Chinese medicine preparation for treating habitual abortion
CN102784362B (en) Externally applied medicine for treating dysphasia and preparation method thereof
CN105456538A (en) Drug for treating osteoporosis
CN105749077A (en) Traditional Chinese medicine composition for treating female infertility
CN104173995A (en) Traditional Chinese medicine preparation for treating dysmenorrhea
CN104306865A (en) Traditional Chinese medicine preparation for treating threatened abortion
CN104042778A (en) Foundation strengthening and sperm-producing soup
CN104107304A (en) Traditional Chinese medicinal composition for treating poliosis
CN103446292B (en) Traditional Chinese medicine decoction for treating lumbocrural pains
CN104173963A (en) Traditional Chinese medicinal composition for treating spleen-stomach yang-deficiency cold type infertility and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140226

Termination date: 20150415

EXPY Termination of patent right or utility model